<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Comments on: Linguistics: &quot;Salami-slicing&quot; Orphan Drugs</title>
	<atom:link href="http://blog.pharmexec.com/2008/10/23/linguistics-salami-slicing-orphan-drugs/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmexec.com/2008/10/23/linguistics-salami-slicing-orphan-drugs/</link>
	<description>The Business of Pharmaceuticals</description>
	<lastBuildDate>Fri, 20 Aug 2010 10:09:38 -0400</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Robert Nowinski</title>
		<link>http://blog.pharmexec.com/2008/10/23/linguistics-salami-slicing-orphan-drugs/comment-page-1/#comment-26359</link>
		<dc:creator>Robert Nowinski</dc:creator>
		<pubDate>Thu, 26 Mar 2009 08:21:44 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmexec.com/?p=355#comment-26359</guid>
		<description>&quot;Salami-Slicing&quot; is certainly interesting language for very small patient groups!</description>
		<content:encoded><![CDATA[<p>&#8220;Salami-Slicing&#8221; is certainly interesting language for very small patient groups!</p>
]]></content:encoded>
	</item>
</channel>
</rss>
